NK Cells Market Report

Europe NK Cells Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jan 09, 2020
  • PAGES：159
  • REPORT CODE：GMM429761
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The NK Cells market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe NK Cells Market Segmentations:

    By Player:

    • Takeda Pharmaceutical (Japan)

    • NKT Therapeutics (USA)

    • Affimed NV (Netherlands)

    • Bristol-Myers Squibb (USA)

    • Altor BioScience Corporation (USA)

    • Chipscreen Biosciences (China)

    • Innate Pharma SA (France)

    By Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    By End-User:

    • Cancer

    • Cardiovascular Diseases

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of NK Cells Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe NK Cells Market Size and Growth Rate of Mogamulizumab from 2014 to 2026

    • 1.3.2 Europe NK Cells Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026

    • 1.3.3 Europe NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe NK Cells Market Size and Growth Rate of Cancer from 2014 to 2026

    • 1.4.2 Europe NK Cells Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • 1.4.3 Europe NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) NK Cells Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of NK Cells Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of NK Cells by Major Types

      • 3.4.1 Market Size and Growth Rate of Mogamulizumab

      • 3.4.2 Market Size and Growth Rate of Lorvotuzumab Mertansine

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of NK Cells Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of NK Cells by Major End-Users

      • 4.4.1 Market Size and Growth Rate of NK Cells for Cancer

      • 4.4.2 Market Size and Growth Rate of NK Cells for Cardiovascular Diseases

      • 4.4.3 Market Size and Growth Rate of NK Cells for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe NK Cells Production Analysis by Top Regions

    • 5.2 Europe NK Cells Consumption Analysis by Top Regions

    • 5.3 Europe NK Cells Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.2 UK NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.3 France NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) NK Cells Production, Import, Consumption and Export Analysis

    6 Product Circulation of NK Cells Market among Top Countries

    • 6.1 Top 5 Export Countries in NK Cells Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in NK Cells Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in NK Cells Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in NK Cells Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in NK Cells Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in NK Cells Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany NK Cells Landscape Analysis

    • 7.1 Germany NK Cells Landscape Analysis by Major Types

    • 7.2 Germany NK Cells Landscape Analysis by Major End-Users

    8. UK NK Cells Landscape Analysis

    • 8.1 UK NK Cells Landscape Analysis by Major Types

    • 8.2 UK NK Cells Landscape Analysis by Major End-Users

    9. France NK Cells Landscape Analysis

    • 9.1 France NK Cells Landscape Analysis by Major Types

    • 9.2 France NK Cells Landscape Analysis by Major End-Users

    10. Italy NK Cells Landscape Analysis

    • 10.1 Italy NK Cells Landscape Analysis by Major Types

    • 10.2 Italy NK Cells Landscape Analysis by Major End-Users

    11. Spain NK Cells Landscape Analysis

    • 11.1 Spain NK Cells Landscape Analysis by Major Types

    • 11.2 Spain NK Cells Landscape Analysis by Major End-Users

    12. Poland NK Cells Landscape Analysis

    • 12.1 Poland NK Cells Landscape Analysis by Major Types

    • 12.2 Poland NK Cells Landscape Analysis by Major End-Users

    13. Russia NK Cells Landscape Analysis

    • 13.1 Russia NK Cells Landscape Analysis by Major Types

    • 13.2 Russia NK Cells Landscape Analysis by Major End-Users

    14. Switzerland NK Cells Landscape Analysis

    • 14.1 Switzerland NK Cells Landscape Analysis by Major Types

    • 14.2 Switzerland NK Cells Landscape Analysis by Major End-Users

    15. Turkey NK Cells Landscape Analysis

    • 15.1 Turkey NK Cells Landscape Analysis by Major Types

    • 15.2 Turkey NK Cells Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Landscape Analysis by Top Countries

      • 16.3.1 Denmark NK Cells Market Volume and Growth Rate

      • 16.3.2 Finland NK Cells Market Volume and Growth Rate

      • 16.3.3 Norway NK Cells Market Volume and Growth Rate

      • 16.3.4 Sweden NK Cells Market Volume and Growth Rate

      • 16.3.6 Iceland NK Cells Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Landscape Analysis by Top Countries

      • 17.3.1 Belgium NK Cells Market Volume and Growth Rate

      • 17.3.2 Netherlands NK Cells Market Volume and Growth Rate

      • 17.3.3 Luxembourg NK Cells Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) NK Cells Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) NK Cells Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) NK Cells Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) NK Cells Landscape Analysis by Top Countries

      • 18.3.1 Estonia NK Cells Market Volume and Growth Rate

      • 18.3.2 Latvia NK Cells Market Volume and Growth Rate

      • 18.3.3 Lithuania NK Cells Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Takeda Pharmaceutical (Japan)

      • 19.1.1 Takeda Pharmaceutical (Japan) Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 NKT Therapeutics (USA)

      • 19.2.1 NKT Therapeutics (USA) Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Affimed NV (Netherlands)

      • 19.3.1 Affimed NV (Netherlands) Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Bristol-Myers Squibb (USA)

      • 19.4.1 Bristol-Myers Squibb (USA) Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Altor BioScience Corporation (USA)

      • 19.5.1 Altor BioScience Corporation (USA) Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Chipscreen Biosciences (China)

      • 19.6.1 Chipscreen Biosciences (China) Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Innate Pharma SA (France)

      • 19.7.1 Innate Pharma SA (France) Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    The List of Tables and Figures (Totals 108 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Europe NK Cells Market Size and Growth Rate of Mogamulizumab from 2014 to 2026

    • Figure Europe NK Cells Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026

    • Figure Europe NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe NK Cells Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Europe NK Cells Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • Figure Europe NK Cells Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure UK NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure France NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Italy NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Spain NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Poland NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Russia NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Canada NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Finland NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Norway NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania NK Cells Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of NK Cells Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of NK Cells

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of NK Cells by Different Types from 2014 to 2026

    • Table Consumption Share of NK Cells by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Mogamulizumab

    • Figure Market Size and Growth Rate of Lorvotuzumab Mertansine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of NK Cells by Different End-Users from 2014 to 2026

    • Table Consumption Share of NK Cells by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Others

    • Table Europe NK Cells Production by Major Regions

    • Table Europe NK Cells Production Share by Major Regions

    • Figure Europe NK Cells Production Share by Major Countries and Regions in 2014

    • Table Europe NK Cells Consumption by Major Regions

    • Table Europe NK Cells Consumption Share by Major Regions

    • Table Germany NK Cells Production, Import, Consumption and Export Analysis

    • Table UK NK Cells Production, Import, Consumption and Export Analysis

    • Table France NK Cells Production, Import, Consumption and Export Analysis

    • Table Italy NK Cells Production, Import, Consumption and Export Analysis

    • Table Spain NK Cells Production, Import, Consumption and Export Analysis

    • Table Poland NK Cells Production, Import, Consumption and Export Analysis

    • Table Russia NK Cells Production, Import, Consumption and Export Analysis

    • Table Switzerland NK Cells Production, Import, Consumption and Export Analysis

    • Table Turkey NK Cells Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) NK Cells Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in NK Cells Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in NK Cells Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in NK Cells Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in NK Cells Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany NK Cells Consumption by Types from 2014 to 2026

    • Table Germany NK Cells Consumption Share by Types from 2014 to 2026

    • Table Germany NK Cells Consumption by End-Users from 2014 to 2026

    • Table Germany NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table UK NK Cells Consumption by Types from 2014 to 2026

    • Table UK NK Cells Consumption Share by Types from 2014 to 2026

    • Table UK NK Cells Consumption by End-Users from 2014 to 2026

    • Table UK NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table France NK Cells Consumption by Types from 2014 to 2026

    • Table France NK Cells Consumption Share by Types from 2014 to 2026

    • Table France NK Cells Consumption by End-Users from 2014 to 2026

    • Table France NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Italy NK Cells Consumption by Types from 2014 to 2026

    • Table Italy NK Cells Consumption Share by Types from 2014 to 2026

    • Table Italy NK Cells Consumption by End-Users from 2014 to 2026

    • Table Italy NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Spain NK Cells Consumption by Types from 2014 to 2026

    • Table Spain NK Cells Consumption Share by Types from 2014 to 2026

    • Table Spain NK Cells Consumption by End-Users from 2014 to 2026

    • Table Spain NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Poland NK Cells Consumption by Types from 2014 to 2026

    • Table Poland NK Cells Consumption Share by Types from 2014 to 2026

    • Table Poland NK Cells Consumption by End-Users from 2014 to 2026

    • Table Poland NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Russia NK Cells Consumption by Types from 2014 to 2026

    • Table Russia NK Cells Consumption Share by Types from 2014 to 2026

    • Table Russia NK Cells Consumption by End-Users from 2014 to 2026

    • Table Russia NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland NK Cells Consumption by Types from 2014 to 2026

    • Table Switzerland NK Cells Consumption Share by Types from 2014 to 2026

    • Table Switzerland NK Cells Consumption by End-Users from 2014 to 2026

    • Table Switzerland NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Turkey NK Cells Consumption by Types from 2014 to 2026

    • Table Turkey NK Cells Consumption Share by Types from 2014 to 2026

    • Table Turkey NK Cells Consumption by End-Users from 2014 to 2026

    • Table Turkey NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) NK Cells Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) NK Cells Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NK Cells Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NK Cells Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NK Cells Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NK Cells Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NK Cells Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) NK Cells Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries NK Cells Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Takeda Pharmaceutical (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical (Japan)

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical (Japan)

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical (Japan)

    • Table Product and Service Introduction of Takeda Pharmaceutical (Japan)

    • Table Company Profile and Development Status of NKT Therapeutics (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NKT Therapeutics (USA)

    • Figure Sales and Growth Rate Analysis of NKT Therapeutics (USA)

    • Figure Revenue and Market Share Analysis of NKT Therapeutics (USA)

    • Table Product and Service Introduction of NKT Therapeutics (USA)

    • Table Company Profile and Development Status of Affimed NV (Netherlands)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed NV (Netherlands)

    • Figure Sales and Growth Rate Analysis of Affimed NV (Netherlands)

    • Figure Revenue and Market Share Analysis of Affimed NV (Netherlands)

    • Table Product and Service Introduction of Affimed NV (Netherlands)

    • Table Company Profile and Development Status of Bristol-Myers Squibb (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb (USA)

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb (USA)

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb (USA)

    • Table Product and Service Introduction of Bristol-Myers Squibb (USA)

    • Table Company Profile and Development Status of Altor BioScience Corporation (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor BioScience Corporation (USA)

    • Figure Sales and Growth Rate Analysis of Altor BioScience Corporation (USA)

    • Figure Revenue and Market Share Analysis of Altor BioScience Corporation (USA)

    • Table Product and Service Introduction of Altor BioScience Corporation (USA)

    • Table Company Profile and Development Status of Chipscreen Biosciences (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences (China)

    • Figure Sales and Growth Rate Analysis of Chipscreen Biosciences (China)

    • Figure Revenue and Market Share Analysis of Chipscreen Biosciences (China)

    • Table Product and Service Introduction of Chipscreen Biosciences (China)

    • Table Company Profile and Development Status of Innate Pharma SA (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate Pharma SA (France)

    • Figure Sales and Growth Rate Analysis of Innate Pharma SA (France)

    • Figure Revenue and Market Share Analysis of Innate Pharma SA (France)

    • Table Product and Service Introduction of Innate Pharma SA (France)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US